Althea and Protein'eXpert pool resources

By Nick Taylor

- Last updated on GMT

Related tags Dna Escherichia coli

US firm Althea Technologies and Protein'eXpert have teamed up to
provide a broad array of biomanufacturing services, from protein
engineering right through to commercial-scale production.

Under the terms of the agreement French contract research and manufacturing services (CRAMS) company Protein'eXpert will share its capacity with contract manufacturer Althea in order to better serve their respective clients. The transatlantic collaboration brings together Protein'eXpert's advanced protein engineering, process development and optimisation expertise and Althea's cGMP manufacturing capacity and fill/finish services from Phase I clinical to commercial manufacturing. The deal follows a trend in outsourcing of biomanufacturing services for clients to seek partners which can provide the whole range of services from early-stage development through to commercialisation, to make scale-up easier and avoid the financial and time cost of swapping CMOs. Dr Tristan Rousselle, CEO of Protein'eXpert, said: "The partnership with Althea Technologies is a great opportunity for us. Their very strong position on the US market and their outstanding production facilities shall perfectly complement our expertise and set of services based on recombinant protein engineering, development and small scale cGMP production​." Through the creation of its integrated subsidiary, PX'Pharma, Protein'eXpert has already gained some in-house protein biomanufacturing capacity. However, Althea has significantly more manufacturing capacity, with the recent construction of its 30,000 sq ft San Diego facility greatly improving its ability to cater for clients from preclinical through to commercial scale production. This site has the capacity for production of active pharmaceutical ingredients (APIs) and aseptic fill and finish capabilities, which complements Althea's other plant that specializes in production of plasmid DNA, recombinant proteins and lyophilisation. In contrast to these broad capabilities Protein'eXpert's expertise is highly focused upon tackling "highly complex and recalcitrant protein projects​" and taking them to production stages. Through such projects Protein'eXpert has worked on more than 150 protein related products, building a knowledge base covering a range of therapeutic and target proteins. The cooperation offers more than just technological gain though, with both companies eager to gain access to the other's primary location. As Rousselle explained Althea's strength in the US is an important factor for Protein'eXpert as is attempts to expand beyond its geographical homeland and into the lucrative North American market. In addition Althea has been looking to gain a foothold in France for several months and has been working with the Invest in France Agency to achieve this goal. The company is said to be attracted to the expertise that is present in the Lyonbiopôle cluster and the incentives which have recently been implemented by the French government.

Related news

Show more

Related products

show more

The Right CDMO Can Unlock Faster Drug Development

The Right CDMO Can Unlock Faster Drug Development

Content provided by Lonza Small Molecules | 15-May-2023 | Interview

Drug development presents biotech companies with ever-changing challenges. Enabling a faster end-to-end process requires seamless flexibility and extensive...

SDTM supplemental qualifiers explained

SDTM supplemental qualifiers explained

Content provided by Formedix | 12-May-2023 | White Paper

What are SDTM supplemental qualifiers? In short, these are variables in non-CDISC datasets that cannot be mapped to a variable that matches the SDTM standard....

Plan for success with process liquid and buffer preparation

Plan for success with process liquid and buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 25-Apr-2023 | White Paper

Setting the groundwork for successful scale-up is essential for getting a therapeutic to market quickly and efficiently, but navigating the unknowns associated...

Related suppliers

Follow us


View more